Selected Works of Sergio Jiménez, MD, MACR
Sergio A. Jimenez
Director, The Scleroderma Center
Co-Director, Jefferson Institute of Molecular Medicine
Professor and Director, Division of Connective Tissue Diseases, Jefferson Medical College
Thomas Jefferson University
Molecular ablation of TGF-beta signaling pathways by tyrosine kinase inhibition: The coming of a promising new era in the treatment of tissue fibrosis
Joel Rosenbloom, Thomas Jefferson University and Sergio A. Jimenez, Thomas Jefferson University
DATE: January 2008
SOURCE: Arthritis and Rheumatism, 58(8):2219-2224
RELATED URL: http://www3.interscience.wiley.com/journal/121357989/abstract
ABOUT THIS DOCUMENT:
This article has been peer reviewed. It is the authors' final version prior to publication. Copyright © 2008 by Wiley Interscience.